🇺🇸 FDA
Patent

US 12403087

Topical antiviral compositions, delivery systems, and methods of using the same

granted A61KA61K31/675A61K33/00

Quick answer

US patent 12403087 (Topical antiviral compositions, delivery systems, and methods of using the same) held by Ligand Pharmaceuticals Incorporated expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/675, A61K33/00, A61K47/02, A61K47/10